- Filed
- May 2, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Apr 25, 2025 | 348.88M sh |
| Long Term Debt | Q3 2025 · Mar 28, 2025 | $4.91B |
| Long Term Debt | Q3 2025 · Jun 28, 2024 | $5.68B |
| Cash And Equivalents | Q3 2025 · Mar 28, 2025 | $3.48B |
| Cash And Equivalents | Q3 2025 · Jun 28, 2024 | $1.55B |
| Current Liabilities | Q3 2025 · Mar 28, 2025 | $5.18B |
| Current Liabilities | Q3 2025 · Jun 28, 2024 | $6.09B |
| Total Liabilities | Q3 2025 · Mar 28, 2025 | $10.96B |
| Total Liabilities | Q3 2025 · Jun 28, 2024 | $13.14B |
| Current Assets | Q3 2025 · Mar 28, 2025 | $8.09B |
| Current Assets | Q3 2025 · Jun 28, 2024 | $8.06B |
| Total Assets | Q3 2025 · Mar 28, 2025 | $16.37B |
| Total Assets | Q3 2025 · Jun 28, 2024 | $24.19B |
| Shares Diluted | Q3 2025 · Mar 29, 2024 | 335M sh |
| Shares Diluted | Q3 2025 · Mar 29, 2024 | 324M sh |
| Capex | Q3 2025 · Mar 29, 2024 | $371M |
| Operating Cash Flow | Q3 2025 · Mar 29, 2024 | −$660M |
| Stockholders Equity | Q3 2025 · Mar 29, 2024 | $10.12B |
| Stockholders Equity | Q3 2025 · Dec 29, 2023 | $10.07B |
| Stockholders Equity | Q3 2025 · Sep 29, 2023 | $10.23B |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | $10.96B |
| Eps Diluted | Q3 2025 · Mar 29, 2024 | $0.34 |
| Eps Diluted | Q3 2025 · Mar 29, 2024 | −$2.72 |
| Eps Basic | Q3 2025 · Mar 29, 2024 | $0.35 |
| Eps Basic | Q3 2025 · Mar 29, 2024 | −$2.72 |
| Sga Expense restated | Q3 2025 · Mar 29, 2024 | $176M |
| Sga Expense restated | Q3 2025 · Mar 29, 2024 | $542M |
| Net Income | Q3 2025 · Mar 29, 2024 | $135M |
| Net Income | Q3 2025 · Mar 29, 2024 | −$837M |
| Net Income | Q3 2025 · Dec 29, 2023 | −$287M |
| Net Income | Q3 2025 · Sep 29, 2023 | −$685M |
| Operating Income restated | Q3 2025 · Mar 29, 2024 | $94M |
| Operating Income restated | Q3 2025 · Mar 29, 2024 | −$312M |
| Gross Profit restated | Q3 2025 · Mar 29, 2024 | $519M |
| Gross Profit restated | Q3 2025 · Mar 29, 2024 | $1.08B |
| Cost Of Revenue restated | Q3 2025 · Mar 29, 2024 | $1.23B |
| Cost Of Revenue restated | Q3 2025 · Mar 29, 2024 | $3.24B |
| Revenue restated | Q3 2025 · Mar 29, 2024 | $1.75B |
| Revenue restated | Q3 2025 · Mar 29, 2024 | $4.31B |